A novel class of potent NF-κB signaling inhibitors

Bioorganic and Medicinal Chemistry Letters

Volumn 17, Issue 21, 2007, Pages 5858-5862

  Leban, Johann ^a   Baierl, Marcel ^a   Mies, Jan ^a   Trentinaglia, Viola ^a   Rath, Sandra ^a   Kronthaler, Kerstin ^a   Wolf, Kristina ^a   Gotschlich, Astrid ^a   Seifert, Markus H J ^a  

^a 4SC AG   (Germany)

Author keywords

Anti inflammatory; Anti viral; Inhibitor; NF B; Nuclear factor B; Signaling

Indexed keywords

BENZIMIDAZOLE DERIVATIVE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PIPERAZINE DERIVATIVE; PROTEASOME INHIBITOR;

ANTIINFLAMMATORY ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; DRUG SCREENING; DRUG STRUCTURE; PERIPHERAL BLOOD MONONUCLEAR CELL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REPORTER GENE;

CELL PROLIFERATION; NF-KAPPA B; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; SIGNAL TRANSDUCTION;

EID: 34548834460     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2007.08.022     Document Type: Article

References (22)

1. Karin M., and Greten R. Nat. Rev. Immunol. 5 (2005) 749
2. Schulze-Luehrmann J., and Ghosh S. Immunity 25 (2006) 701
3. Thome M. Nat. Rev. Immunol. 4 (2004) 348
4. Nimmerjahn F., Dudziak D., Dirmeier U., Hobom G., Riedel A., Schlee M., Staudt L.M., Rosenwald A., Behrends U., Bornkamm G.W., and Mautner J. J. Gen. Virol. 85 (2004) 2347
5. Wurzer W.J., Ehrhardt C., Pleschka S., Berberich-Siebelt F., Wolff T., Walczak H., Planz O., and Ludwig S. J. Biol. Chem. 279 (2004) 30931
6. Wei L., Sandbulte M.R., Thomas P.G., Webby R.J., Homayouni R., and Pfeffer L.M. J. Biol. Chem. 281 (2006) 11678
7. Pfeffer L.M., Kim J.G., Carrigan D.J., Baker D.P., Wei L., and Homayouni R. J. Biol. Chem. 279 (2004) 31304
8. Merfort I. Expert Opin. Ther. Pat. 16 (2006) 797
9. http://people.bu.edu/gilmore/nf-kb/inhibitors/.
10. Adams J., Palombella V.J., and Elliott P.J. Invest. New Drugs 18 (2000) 109
11. Virtual screening: proteasome X-ray structure (PDB ID 1IRU) was used for virtual screening due to the sequence identity within the chymotryptic subpocket of the bovine proteasome located on the L and M chain and the human proteasome X and HC5 chains. Protein-ligand docking was used for virtual screening with the binding pocket defined around the catalytically active threonine (THR1) containing the subpockets S1, S2, and S3. Virtual high-throughput screening was done using the docking engine of 4SCan/ProPose (Seifert, M. H.; Wolf, K.; Vitt, D. DDT Biosilico 2003, 1, 143.; Seifert, M. H.; Schmitt, F.; Herz, T.; Kramer, B. J. Mol. Model. 2004, 10, 342) on 4SC's database of five million chemical compounds. The 5000 best docking hits were submitted to filtering: a distance cutoff of 10 Å to THR1 was applied, molecular properties (molecular weight, topological polar surface area, number of rotational bonds) were filtered, unwanted functional groups were omitted, and finally a visual inspection of the docked structures yielded a ranking list. A representative set of 236 compounds was selected for purchasing and biochemical testing.
12. 50 values data were fitted to a four parameter logistic function using SigmaPlot.
13. 4/well and allowed to attach overnight. The cells were subsequently incubated for 5 h with described compounds at 100, 30, 10, 3, 1, 0.3, 0.1, and 0 μM and then stimulated with 10 ng/ml TNF-α for 22 h. The supernatant of the cell was analyzed for SEAP activity using a chemiluminescent SEAP reporter gene assay (Roche, Mannheim, Germany), and a cell viability assay was prepared using a CellTiter-BluTM Cell Viability Assay (Promega, Mannheim, Germany). For each concentration of the compound four replicates were measured.
14. Magaud J.P., Sargent I., and Mason D.Y. J. Immunol. Methods 106 (1988) 95
15. Leban J., Kralik M., Mies J., Gassen M., Tentschert K., and Baumgartner R. Bioorg. Med. Chem. Lett. 15 (2005) 4854
16. Know, P.; O'Sullivan, M.; Lentfer, H. Patent application WO 2004/058750, 2004.
17. All compounds were characterized by MS and NMR (300 MHz) and exhibited satisfactory properties.
18. Lionel J. J. Med. Chem. 6 (1963) 601
19. Ohnishi, H.; Kosuzume, H.; Mizota M.; Suzuki, Y.; Mochida, E. European patent EP 1984/0116421, 1984.
20. Fusaka, T.; Ujikawa, O.; Kajiwara, T.; Tanaka, Y, Patent WO9711075, 1997.
21. Proteasome-Glo™ Cell-Based Assay Technical Bulletin (TB346), 2006 (Promega, Mannheim, Germany).
22. Leban, J.; Schmitt, H.; Wolf K, Pegoraro S, Wuzik A. US Patent application US 2006/247253, 2006.